Skip to main contentAll experts

DrMobeen Rathore

ASO CHAIR & PROF

JX-PEDIATRICS-JACKSONVILLE

Orcid identifier0000-0001-7416-9755 (opens in a new tab)⁠
  • ASO CHAIR & PROF
    JX-PEDIATRICS-JACKSONVILLE

GRANTS

  • GRANT
    Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare
    US Health Resources and Serv Admn Hiv/Aids11 Sep 2026 - 31 Jul 2030
    Active
  • GRANT
    A Phase 3, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Cabotegravir Ultra Long-acting Plus Rilpivirine Ultra Long-acting or Cabotegravir Long-acting Plus Rilpivirine Long-acting in Adults and Adolescents with HIV who are Virologically Suppressed on ART
    Glaxosmithkline17 Aug 2026 - 16 Aug 2031
    Active
  • GRANT
    Clinical Evaluation of the Panther Fusion M. gen Res Assay in Urogenital Specimens
    Hologic Inc11 Mar 2026 - 10 Mar 2031
    Active
  • GRANT
    Ryan White Part A 2026-2027
    US Health Resources and Serv Admn Hiv/Aids11 Feb 2026 - 28 Feb 2027
    Active
  • GRANT
    International Maternal Pediatric Adolescent AIDS Clinical Trials Network
    National Institute of Health Nichd21 Nov 2025 - 30 Nov 2026
    Active
  • GRANT
    WO3/TO5 – IMPAACT 2037v2 – Open-Label, Phase I Study of the Safety and Pharmacokinetics of PGT121.414.LS alone and in combination with VRC07-523LS in Infants Exposed to HIV-1
    National Institute of Health Nichd6 Aug 2025 - 31 May 2027
    Active
  • GRANT
    Authorization to Proceed WO2/TO7 IMPAACT 2041
    National Institute of Health Nichd5 Jun 2025 - 31 May 2027
    Active
  • GRANT
    Protocol P1115 Very Early Intensive Treatment of Infants Living with HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study ("Protocol")
    National Institute of Health Nichd2 May 2025 - 31 May 2027
    Active
  • GRANT
    Ryan White Title III Outpatient EIS Program
    US Health Resources and Serv Administration28 Apr 2025 - 30 Apr 2028
    Active
  • GRANT
    PHACS HOPE Closeout
    Harvard University1 Mar 2025 - 30 Jun 2025
    Expired
  • GRANT
    Ryan White Part A 2025-2026
    US Health Resources and Serv Admn Hiv/Aids26 Feb 2025 - 28 Feb 2026
    Expired
  • GRANT
    A Phase 3b, open label, randomized, standard-of-care control arm, multicenter, superiority study evaluating the efficacy, safety and tolerability of injectable CAB LA + RPV LA in viremic participants living with HIV-1 (CROWN)
    Glaxosmithkline23 Dec 2024 - 23 Dec 2029
    Active
  • GRANT
    CMS Employee Interchange Agreement, Dr. Rathore, CMS Medical Director Statewide Pediatric HIV Physician Consultant
    Florida Department of Health Childrens Med Servs3 Oct 2024 - 24 Feb 2025
    Expired
  • GRANT
    2923-3A: Evaluating the Association Between Opioid Non-tolerance and the Risk of Respiratory Depression as well as Non-fatal and Fatal Overdose in Pediatric Patients Prescribed OxyContin
    Purdue Pharma L P10 Sep 2024 - 21 Sep 2025
    Closed
  • GRANT
    Pediatric HIV/AIDS Cohort Study (PHACS) DIALECT Study
    National Institute of Health Nichd1 Aug 2024 - 4 Jun 2025
    Expired
  • GRANT
    Pediatric HIV/AIDS Cohort Study (PHACS): 2024-2025, Y5 AMP Up Series
    National Institute of Health Nichd28 Jul 2024 - 4 Jun 2025
    Expired
  • GRANT
    Pediatric HIV/AIDS Cohort Study (PHACS): 2024-2025, Y5 SMARTT
    National Institute of Health Nichd25 Jul 2024 - 30 Jun 2025
    Expired
  • GRANT
    Ryan White Part A and Minority AIDS Initiative
    US Health Resources and Serv Admn Hiv/Aids20 Mar 2024 - 28 Feb 2025
    Expired
  • GRANT
    Health Outcomes around Pregnancy and Exposure to HIV/ARVs (HOPE) - Extending the Reach of PHACS to Examine Women's Health
    National Institute of Health Nichd1 Mar 2024 - 28 Feb 2025
    Expired
  • GRANT
    Pediatric HIV/AIDS Cohort Study (PHACS) Maternal Mental Health
    National Institute of Health Nichd18 Sep 2023 - 31 Jul 2024
    Expired
  • GRANT
    Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POPS)
    National Institute of Health Nichd24 Aug 2023 - 12 Jul 2027
    Active
  • GRANT
    Pediatric HIV/AIDS Cohort Study (PHACS) AMP Up Series
    National Institute of Health Nichd18 Aug 2023 - 31 Jul 2024
    Expired
  • GRANT
    Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC)
    National Institute of Health Nichd18 Aug 2023 - 31 Jul 2024
    Expired
  • GRANT
    A Phase 1, Randomized, Observer-blind, Placebo-controlled, Age De-escalation Study of the Safety, Tolerability, and Immunogenicity of mRNA-1345 and mRNA-1365 in Participants Aged 5 months to <24 months - Reference Number 275577 USA
    Moderna Therapeutics7 Aug 2023 - 25 Oct 2024
    Closed
  • GRANT
    Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC)
    National Institute of Health Nichd1 Aug 2023 - 31 Jul 2024
    Expired